Bionor Immuno Overview
- Year Founded
-
2000
- Status
-
Acquired/Merged
- Employees
-
4
- Latest Deal Type
-
M&A
- Financing Rounds
-
1
Bionor Immuno General Information
Description
Developer of vaccines. The company creates peptides which are used in vaccines to cause production of desired antibodies.
Contact Information
Website
www.bionorimmuno.comCorporate Office
- Klostergata 33
- 3732 Skien
- Norway
Corporate Office
- Klostergata 33
- 3732 Skien
- Norway
Bionor Immuno Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Bionor Immuno Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Bionor Immuno FAQs
-
When was Bionor Immuno founded?
Bionor Immuno was founded in 2000.
-
Where is Bionor Immuno headquartered?
Bionor Immuno is headquartered in Skien, Norway.
-
What is the size of Bionor Immuno?
Bionor Immuno has 4 total employees.
-
What industry is Bionor Immuno in?
Bionor Immuno’s primary industry is Pharmaceuticals.
-
Is Bionor Immuno a private or public company?
Bionor Immuno is a Private company.
-
What is the current valuation of Bionor Immuno?
The current valuation of Bionor Immuno is .
-
What is Bionor Immuno’s current revenue?
The current revenue for Bionor Immuno is .
-
When was Bionor Immuno acquired?
Bionor Immuno was acquired on 12-Feb-2010.
-
Who acquired Bionor Immuno?
Bionor Immuno was acquired by Bionor Holding.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
